Comment on: suboptimal CD4 gains in HIV-infected patients receiving didanosine plus tenofovir

J Antimicrob Chemother. 2006 Jul;58(1):220-1. doi: 10.1093/jac/dkl203. Epub 2006 May 22.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine / analogs & derivatives*
  • Adenine / therapeutic use
  • Anti-HIV Agents / therapeutic use*
  • CD4 Lymphocyte Count
  • Didanosine / therapeutic use*
  • HIV Infections / drug therapy*
  • Humans
  • Organophosphonates / therapeutic use*
  • Purine-Nucleoside Phosphorylase / antagonists & inhibitors
  • Tenofovir

Substances

  • Anti-HIV Agents
  • Organophosphonates
  • Tenofovir
  • Purine-Nucleoside Phosphorylase
  • Adenine
  • Didanosine